Finland· FI-REL-REL1559
Mmr-Ii
A masern, kombinationen mit mumps und röteln, lebend abgeschwächt product containing measles virus, live, attenuated + mumps virus, live, attenuated + rubella virus, live, attenuated, registered in Finland by Sanofi Pasteur MSD. The same ATC class is registered in 11 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Masern, kombinationen mit mumps und röteln, lebend abgeschwächt is registered in 11 of 19 countries.
Countries holding a registration under ATC J07BD52 (masern, kombinationen mit mumps und röteln, lebend abgeschwächt), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 7 of them publish a price we can compare per daily dose
Masern, kombinationen mit mumps und röteln, lebend abgeschwächt · ATC J07BD52
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
Fimea (Finland)- Active substance
- Measles virus, live, attenuated + Mumps virus, live, attenuated + Rubella virus, live, attenuated
- Manufacturer
- Sanofi Pasteur MSD
- Country
- Finland (FI)
- ATC code
- J07BD52
- ATC class
- Masern, Kombinationen mit Mumps und Röteln, lebend abgeschwächt
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under J07BD52
Masern, kombinationen mit mumps und röteln, lebend abgeschwächt, as other registers publish it.
- CanadaM-M-R IIMERCK CANADA INC
- NorwayM-M-RvaxproMerck Sharp & Dohme B.V.
- DenmarkM-M-RvaxproMerck Sharp & Dohme B.V.
- FinlandM-M-RvaxproMerck Sharp & Dohme B.V.
- DenmarkM-M-RvaxproMerck Sharp & Dohme B.V.
- PolandM-M-RvaxProMerck Sharp & Dohme B.V.
- BelgiumM-M-RVaxProMerck Sharp & Dohme
- BelgiumM-M-RVaxProMerck Sharp & Dohme
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/9be66446-5b6f-4b48-b794-ad04aff71236 GET /v1/drugs/9be66446-5b6f-4b48-b794-ad04aff71236?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": null,
"form": "injektiokuiva-aine ja liuotin, liuosta varten",
"route": null,
"ddd_unit": null,
"strength": null,
"atc_label": "tuhkarokko-sikotauti-vihurirokkorokote, elävä heikennetty virus",
"ma_number": "8456",
"auth_status": "Myyntilupa peruuntunut",
"eu_ma_number": null,
"fimea_rel_id": "REL1559",
"authorised_at": "1983-02-23"
}See everything about masern, kombinationen mit mumps und röteln, lebend abgeschwächt.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.